Impaired Glucose Metabolism in Patients with Heart Failure: Pathophysiology and Possible Treatment Strategies

Author： Alexander Tenenbaum Enrique Z. Fisman

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.5, 2004-01, pp. : 269-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolvaptan a possible adjunct treatment for heart failure

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure: Pathophysiology and Current Experience

By Seidl K. Rameken M. Vater M. Senges J.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 219-226

Adis International

Access to resources Recommend Favorite

Treatment of Heart Failure in Patients with Diabetes Mellitus

By Lavine S.J. Gellman S.D.

Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. : 285-307

Adis International

Access to resources Recommend Favorite

Drug Treatment of Patients with Decompensated Heart Failure

By Mills R.M. Hobbs R.E.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 119-125

Adis International

Access to resources Recommend Favorite

Advanced Strategies in the Diagnosis and Treatment of Patients with Coronary Artery Disease and Heart Failure: When Heart Failure Causes Ischemia and Angiotensin Converting Enzyme Inhibitor and Betablockers Helps in Diuresis

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 511-516

Bentham Science Publishers

Access to resources Recommend Favorite